查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513934

腎結石管理設備的全球市場

Kidney Stone Management Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球腎結石管理設備市場預計將達到 23 億美元

2023 年全球腎結石管理設備市場估計為 17 億美元，預計到 2030 年將達到 23 億美元，2023-2030 年分析期間複合年成長率為 4.8%。輸尿管鏡檢查是本報告分析的細分市場之一，預計複合年成長率為 5.4%，到分析期結束時將達到 13 億美元。分析期間碎石機領域的複合年成長率預計為 4.3%。

美國市場預計將達到4.466億美元，中國預計複合年成長率為8.1%。

預計 2023 年美國腎結石管理設備市場規模將達 4.466 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達4.945億美元，2023年至2030年複合年成長率為8.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.4% 和 3.9%。在歐洲，德國的複合年成長率預計為 3.1%。

腎結石管理設備 - 主要趨勢和促進因素

腎結石管理設備是專門用於診斷、治療和管理腎結石的醫療設備，腎結石是一種影響全球數百萬人的常見泌尿系統疾病。這些設備包括多種技術和設備，包括體外震波碎石機 (ESWL)、輸尿管鏡、腎臟鏡、雷射碎石機和支架。 ESWL 裝置使用衝擊波將腎結石分解成更小的碎片，讓它們自行排出。輸尿管鏡和腎鏡是內視鏡器械，可以分別直接觀察和清除泌尿道和腎臟的結石。雷射碎石機利用雷射能量碎石，是一種高精度、微創的治療方法。支架用於確保尿液流動、預防併發症並幫助結石去除或碎裂後的恢復。這些設備對於根據腎結石的大小、位置和成分提供有效的治療方法至關重要。

腎結石管理設備市場正在受到多種趨勢的影響，反映了醫療技術的進步和患者照護方法的變化。一個重要的趨勢是，由於患者需要更快的恢復時間和更低的併發症發生率，因此擴大採用微創手術。這導致輸尿管軟鏡和雷射碎石機的使用越來越多，它們可以準確有效地去除結石，同時將不適感降到最低。技術進步也增強了 ESWL 設備的功能，提高了其準確性和有效性。另一個值得注意的趨勢是將超音波和透視等成像技術整合到結石管理設備中，以幫助可視化和定位結石。此外，飲食和肥胖等生活方式因素導致腎結石盛行率不斷上升，這推動了對先進管理解決方案的需求。此外，支架設計的創新正在減少與支架相關的不適和併發症，並改善患者的治療結果。

腎結石管理設備市場的成長受到多種因素的推動。技術的進步提高了取石手術的準確性、效率和安全性，使更廣泛的患者更容易獲得和有效地進行取石手術。由於飲食改變、脫水和久坐的生活方式，腎結石盛行率不斷上升，這加大了對有效管理解決方案的需求。此外，人們對腎結石認知的提高和先進治療方案的可用性正在導致更多患者尋求及時的醫療干預。微創手術的趨勢也是主要動力。這是因為這些手術可以減輕疼痛、縮短住院時間並加快復原時間。醫療保健提供者擴大採用這些先進設備來改善患者護理和治療結果。此外，可攜式且易於使用的設備的發展使得門診病人和低度開發地區更容易進行腎結石治療。政府對腎結石治療的支持和優惠報銷政策進一步推動了市場成長。總體而言，這些因素正在推動腎結石治療設備市場的強勁成長，滿足對有效和高效治療方案不斷成長的需求。

受訪企業範例（共48家）

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-6467

Global Kidney Stone Management Devices Market to Reach US$2.3 Billion by 2030

The global market for Kidney Stone Management Devices estimated at US$1.7 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Lithotripsy segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$446.6 Million While China is Forecast to Grow at 8.1% CAGR

The Kidney Stone Management Devices market in the U.S. is estimated at US$446.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$494.5 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Kidney Stone Management Devices - Key Trends and Drivers

Kidney stone management devices are specialized medical tools designed to diagnose, treat, and manage kidney stones, a common urological condition affecting millions worldwide. These devices encompass a range of technologies and instruments, including extracorporeal shock wave lithotripsy (ESWL) machines, ureteroscopes, nephroscopes, laser lithotripters, and stents. ESWL machines use shock waves to break down kidney stones into smaller fragments that can be passed naturally. Ureteroscopes and nephroscopes are endoscopic devices that allow for the direct visualization and removal of stones within the urinary tract and kidney, respectively. Laser lithotripters utilize laser energy to fragment stones, offering a minimally invasive solution with high precision. Stents are used to ensure the free flow of urine after the removal or fragmentation of stones, preventing complications and aiding recovery. These devices are critical in providing effective treatment options tailored to the size, location, and composition of kidney stones.

Several trends are shaping the kidney stone management devices market, reflecting advancements in medical technology and changes in patient care approaches. One significant trend is the increasing adoption of minimally invasive procedures, driven by patient demand for reduced recovery times and lower complication rates. This has led to the growing use of flexible ureteroscopes and laser lithotripters, which allow for precise and efficient stone removal with minimal discomfort. Technological advancements are also enhancing the capabilities of ESWL machines, improving their accuracy and effectiveness. The integration of imaging technologies, such as ultrasound and fluoroscopy, with stone management devices is another notable trend, enabling better visualization and targeting of stones. Additionally, the rise in the prevalence of kidney stones, partly due to lifestyle factors such as diet and obesity, is driving the demand for advanced management solutions. Furthermore, innovations in stent design are improving patient outcomes by reducing stent-related discomfort and complications.

The growth in the kidney stone management devices market is driven by several factors. Technological advancements are enhancing the precision, efficiency, and safety of stone removal procedures, making them more accessible and effective for a broader range of patients. The increasing prevalence of kidney stones, fueled by dietary changes, dehydration, and sedentary lifestyles, is expanding the need for effective management solutions. Additionally, the growing awareness of kidney stone disease and the availability of advanced treatment options are encouraging more patients to seek timely medical intervention. The trend towards minimally invasive surgeries is also a significant driver, as these procedures offer reduced pain, shorter hospital stays, and quicker recovery times. Healthcare providers are increasingly adopting these advanced devices to improve patient care and outcomes. Moreover, the development of portable and user-friendly devices is making kidney stone management more accessible in outpatient settings and less developed regions. Government support and favorable reimbursement policies for kidney stone treatments are further propelling market growth. Overall, these factors are fostering robust growth in the kidney stone management devices market, meeting the rising demand for effective and efficient treatment options.

Select Competitors (Total 48 Featured) -

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Kidney Stone Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Kidney Stones Drives Demand for Advanced Management Solutions
    • Increasing Adoption of Minimally Invasive Procedures Propels Growth in Kidney Stone Management Devices
    • Technological Advancements in ESWL Machines Strengthen Business Case for Non-Invasive Treatments
    • Integration of Imaging Technologies Expands Addressable Market Opportunity for Precision Stone Removal
    • Innovations in Stent Design Here's How They Improve Patient Outcomes and Reduce Complications
    • Lifestyle Factors Such as Diet and Obesity Spur Growth in Kidney Stone Management Market
    • Growing Awareness of Kidney Stone Disease Generates Demand for Timely Medical Interventions
    • Development of Flexible Ureteroscopes Drives Adoption of Efficient Stone Removal Techniques
    • Increasing Use of Laser Lithotripters: Here's the Story for Precision and Minimal Discomfort in Stone Management
    • Trend towards Outpatient Procedures Expands Market Reach for Portable and User-Friendly Devices
    • Advances in Endoscopic Technologies Spur Growth in Efficient and Effective Stone Removal Solutions
    • Consumer Demand for Reduced Recovery Times and Lower Complication Rates Drives Minimally Invasive Techniques
    • Expansion of Urology Clinics and Specialized Healthcare Centers Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Kidney Stone Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ureteroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Kidney Stone Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Kidney Stone Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION